Hans-Michael Steffen
Overview
Explore the profile of Hans-Michael Steffen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stegmann S, Vohlen C, Im N, Niehues J, Selle J, Janoschek R, et al.
Sci Rep
. 2025 Feb;
15(1):6416.
PMID: 39984579
Perinatal obesity is associated with an increased risk of metabolic diseases and hepatic dysfunction in offspring. However, the underlying mechanisms of this metabolic programming remain incompletely understood. This study aimed...
2.
Martin A, Lang S, Schifferdecker F, Allo G, Chon S, Neumann-Haefelin C, et al.
J Hypertens
. 2025 Feb;
PMID: 39945743
Backgroundaims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for cardiovascular morbidity and mortality. Another critical risk factor in these patients is arterial hypertension (AH). Although it...
3.
Gulcicegi D, Hannemann J, Burger M, Allo G, Dittmann E, Martin A, et al.
Front Med (Lausanne)
. 2024 Dec;
11:1475997.
PMID: 39669986
Background: Acute decompensation (AD) in patients with liver cirrhosis is associated with a dramatic deterioration in prognosis. Immediate initiation of appropriate recompensation measures is essential to improve patient's outcome, although...
4.
Kasper P, Lang S, Steffen H, Demir M
Liver Int
. 2023 Aug;
43(10):2078-2095.
PMID: 37605624
Alcohol-associated liver disease is the primary cause of liver-related mortality worldwide and one of the most common indications for liver transplantation. Alcoholic hepatitis represents the most acute and severe manifestation...
5.
Kasper P, Demir M, Steffen H
J Hypertens
. 2023 Aug;
41(9):1498-1499.
PMID: 37545370
No abstract available.
6.
Steffen H, Mahanani M, Neuhann F, Nhlema A, Kasper P, de Forest A, et al.
Clin Res Cardiol
. 2023 Jul;
112(11):1650-1663.
PMID: 37414923
Background: Sub-Saharan Africa is one of the regions in the world with the highest numbers of uncontrolled hypertension as well as people living with HIV/AIDS (PLHIV). However, the association between...
7.
Steffen H, Martin A, Lang S, Kasper P
Clin Res Cardiol
. 2023 Apr;
112(7):1003-1004.
PMID: 37118637
No abstract available.
8.
Gillessen J, Reuken P, Hunyady P, Reichert M, Lothschutz L, Finkelmeier F, et al.
J Clin Transl Hepatol
. 2023 Mar;
11(3):626-637.
PMID: 36969893
Background And Aims: Hepatocellular carcinoma (HCC) surveillance in patients at risk is strongly recommended and usually performed by ultrasound (US) semiannually with or without alfa-fetoprotein (AFP) measurements. Quality parameters except...
9.
Kasper P, Demir M, Steffen H
Clin Mol Hepatol
. 2023 Mar;
29(2):390-393.
PMID: 36935647
No abstract available.
10.
Heinzer K, Lang S, Farowski F, Wisplinghoff H, Vehreschild M, Martin A, et al.
Nutr Res
. 2022 Sep;
107:12-25.
PMID: 36162275
In this cross-sectional study, we hypothesized that a high dietary ratio of omega-6 (n-6) to omega-3 (n-3) fatty acids could be associated with an altered gut bacterial composition and with...